Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy.
We report the successful treatment of a 36-year-old man with recalcitrant pemphigus vulgaris by pulsed intravenous immunoglobulin therapy, dexamethasone and cyclophosphamide. In addition to clinical resolution, indirect immunofluorescence antibodies have since largely been undetectable.
Bewley
A P
AP
Department of Dermatology, Southampton University Hospitals NHS Trust, Royal South Hants Hospital, U.K.
Keefe
M
M
D000328:Adult; D001323:Autoantibodies / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D010392:Pemphigus / Q000628:therapy*
D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D003907:Dexamethasone; D003520:Cyclophosphamide